Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?
Introduction: The use of the fixed-dose combination of tramadol/dexketoprofen in Spain and in other countries has increased considerably. The authorized therapeutic indication for this medicinal product is the short-term symptomatic treatment of moderate to severe acute pain in adult patients. The...
Autors principals: | , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Fundación Pharmaceutical Care España
2022-06-01
|
Col·lecció: | Pharmaceutical Care España |
Matèries: | |
Accés en línia: | https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/680 |